Principle Research Solutions, LLC | Spokane, WA
Research site
Site insights
Top conditions
Top treatments
Etrasimod
Dapsone
Crisaborole
BHV-3000
Ritlecitinib
LY4268989
PF-04965842
Ruxolitinib
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Contact this site
Gregory Jared
Verified by this site
Active trials
2 of 8 total trials
The purpose of the study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the treatment of alopecia areata. A...
Enrolling
Alopecia Areata
Drug: Placebo - 50 mg
Drug: Ritlecitinib 50 mg
The main purpose of this study is to evaluate the safety and effectiveness of LY4268989 when compared to placebo in adult participants with moderatel...
Not yet enrolling
Ulcerative Colitis (UC)
Ulcerative Colitis, Active Severe
Drug: Placebo
Drug: LY4268989
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems